Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04579913 · ClinicalTrials.gov registry record

A Multi-center, International Prospective Follow up Study

A clinical trial, sponsored by Medi-Tate.

Terminated
Registry status
17
Enrollment target

NCT04579913 is a clinical trial that was terminated before completion, run by Medi-Tate. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04579913 was terminated before completion, sponsored by Medi-Tate.

TERMINATED
Registry status
17 participants
Enrollment target

Study Summary

The study objective is to assess the safety and efficacy of iTind three to five years following treatment.

Interventions

  • OTHER Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2020-12-21
Est. Completion 2021-04-22

Sponsor

Medi-Tate

2 total trials

What the Registry Record Tells You About NCT04579913

The ClinicalTrials.gov registry entry for NCT04579913 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medi-Tate, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound is the first listed.

NCT04579913 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04579913 about?

NCT04579913 is a clinical study titled "A Multi-center, International Prospective Follow up Study". The study objective is to assess the safety and efficacy of iTind three to five years following treatment.

What is the current status of trial NCT04579913?

This trial is currently terminated. The enrollment target is 17 participants. The study started on 2020-12-21. Estimated completion is 2021-04-22.

What interventions are being tested in trial NCT04579913?

The interventions under investigation include: Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound (OTHER).

Who is sponsoring clinical trial NCT04579913?

This trial is sponsored by Medi-Tate, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.